Modiv Director Shows Confidence with Strategic Stock Purchase at $14.25

Rhea-AI Filing Summary

Director Christopher Raymond Gingras of Modiv Industrial reported insider purchases of Class C common stock on June 25, 2025. The transactions included:

• Purchase of 100 shares at $14.20 per share
• Purchase of 300 shares at $14.25 per share

Following these transactions, Gingras now directly owns 8,096.0071 shares of Class C common stock. The purchases represent a total investment of approximately $5,695. The Form 4 filing was signed by John Raney through power of attorney for Gingras. No derivative securities were involved in these transactions.

Insider Trade Summary

Net Buyer: 400 shares

Net Buy 2 txns

Insider Gingras Christopher Raymond

Role Director

Bought 400 shs ($6K)

Type	Security	Shares	Price	Value
Purchase	COMMON STOCK, CLASS C	100	$14.20	$1K
Purchase	COMMON STOCK, CLASS C	300	$14.25	$4K

Holdings After Transaction: COMMON STOCK, CLASS C — 8,096.0071 shares (Direct)

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 06/25/2025 - 04:56 PM Learn about SEC filing dates

FAQ

How many shares of MDV stock did Director Christopher Gingras purchase on June 25, 2025?

Director Christopher Gingras purchased a total of 400 shares of MDV Class C common stock on June 25, 2025, split between two transactions: 100 shares at $14.20 per share and 300 shares at $14.25 per share.

What is Christopher Gingras's total MDV stock ownership after the June 25, 2025 purchases?

Following the reported transactions, Christopher Gingras beneficially owns 8,096.0071 shares of MDV Class C common stock directly (Form: D).

What was the price range of MDV shares purchased by Director Gingras?

Director Gingras purchased MDV shares at two price points: $14.20 and $14.25 per share on June 25, 2025.

What is Christopher Gingras's role at MDV according to the Form 4?

According to the Form 4 filing, Christopher Raymond Gingras serves as a Director of Modiv Industrial, Inc. (MDV), as indicated by the 'X' marked in the Director box under Section 5 of the form.

Did Christopher Gingras make any derivative securities transactions for MDV?

No, the Form 4 shows no transactions involving derivative securities (such as options or warrants) in Table II. All transactions were direct purchases of Class C common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gingras Christopher Raymond

(Last) (First) (Middle)

2195 SOUTH DOWNING STREET

(Street)

DENVER CO 80210

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MODIV INDUSTRIAL, INC. [ MDV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
COMMON STOCK, CLASS C	06/25/2025		P		100	A	$14.2	7,796.0071	D
COMMON STOCK, CLASS C	06/25/2025		P		300	A	$14.25	8,096.0071	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ John Raney, by Power of Attorney for Christopher R. Gingras	06/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.